Table 4.
Comparison of LGMD and non‐LGMD patients
| Characteristics | LGMD (N = 25) | Non‐LGMD (N = 12) | P‐value | |
|---|---|---|---|---|
| Univariate | Multivariate | |||
| Male, n (%) | 18 (72) | 9 (75) | 0.847 | 0.913 |
| Age at onset, mean (SD) | 41.3 (13.1) | 27.7 (14.9) | 0.008 | 0.017 |
| Disease duration, mean (SD) | 8.9 (4.6) | 8.8 (7.3) | 0.949 | 0.746 |
| Homozygous loss‐of‐function variants, n (%) | 7 (28) | 4 (33) | 1.0 | NA |
| Presence of at least 1 loss‐of‐function variant, n (%) | 19 (76) | 9 (75) | 1.0 | NA |
| Presence of homozygous c.191dupA, n (%) | 4 (16) | 3 (25) | 0.659 | NA |
NA, not applicable.